LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.

Hartmann, Jordan A / Cardoso, Marcella R / Talarico, Maria Cecilia Ramiro / Kenney, Devin J / Leone, Madison R / Reese, Dagny C / Turcinovic, Jacquelyn / O'Connell, Aoife K / Gertje, Hans P / Marino, Caitlin / Ojeda, Pedro E / De Paula, Erich V / Orsi, Fernanda A / Velloso, Licio Augusto / Cafiero, Thomas R / Connor, John H / Ploss, Alexander / Hoelzemer, Angelique / Carrington, Mary /
Barczak, Amy K / Crossland, Nicholas A / Douam, Florian / Boucau, Julie / Garcia-Beltran, Wilfredo F

Cell

2024  Volume 187, Issue 10, Page(s) 2393–2410.e14

Abstract: SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an ... ...

Abstract SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an activating receptor conserved among mammals that recognizes infection-induced stress ligands (e.g., MIC-A/B). We found that SARS-CoV-2 evades NKG2D recognition by surface downregulation of MIC-A/B via shedding, observed in human lung tissue and COVID-19 patient serum. Systematic testing of SARS-CoV-2 proteins revealed that ORF6, an accessory protein uniquely conserved among sarbecoviruses, was responsible for MIC-A/B downregulation via shedding. Further investigation demonstrated that natural killer (NK) cells efficiently killed SARS-CoV-2-infected cells and limited viral spread. However, inhibition of MIC-A/B shedding with a monoclonal antibody, 7C6, further enhanced NK-cell activity toward SARS-CoV-2-infected cells. Our findings unveil a strategy employed by SARS-CoV-2 to evade cytotoxic immunity, identify the culprit immunevasin shared among sarbecoviruses, and suggest a potential novel antiviral immunotherapy.
MeSH term(s) Humans ; SARS-CoV-2/immunology ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; NK Cell Lectin-Like Receptor Subfamily K/metabolism ; COVID-19/immunology ; COVID-19/virology ; Immune Evasion ; Histocompatibility Antigens Class I/immunology ; Histocompatibility Antigens Class I/metabolism ; Animals ; Cytotoxicity, Immunologic ; Down-Regulation ; Lung/immunology ; Lung/virology ; Lung/pathology
Chemical Substances NK Cell Lectin-Like Receptor Subfamily K ; MICB antigen ; Histocompatibility Antigens Class I ; KLRK1 protein, human ; MHC class I-related chain A
Language English
Publishing date 2024-04-22
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 187009-9
ISSN 1097-4172 ; 0092-8674
ISSN (online) 1097-4172
ISSN 0092-8674
DOI 10.1016/j.cell.2024.03.026
Shelf mark
Zs.A 1167: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MG 58: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top